If you’re over 39 years and experiencing blurred vision when reading or doing other close work, you are probably suffering from presbyopia; an age-related condition that affects more than 135 million people in the United States.
Yolia developed the 1st safe, non-invasive and repeatable treatment for presbyopia. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses and specially formulated eye drops – which, when used together leads to superior vision.
After only 5 days of treatment with TVT patients are able to stop using the TVT contact lenses, TVT eye drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia’s TVT improves both near and distance vision, a unique feature no single other alternative can provide.
Company’s Keywords:
biotechnology, medical devices, life sciences, eyewear, consumer goods, medical, consumers, health care, noninvasive vision restoration, presbyopia correction, specialty contact lenses, ophthalmology, optometry
<6
<
<2004
Your request has been submitted successfully.
Own or work here?